These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11257816)

  • 1. [Great discrepancies between European, Dutch and Belgian criteria for the use of statins in the prevention of primary cardiovascular disease in family practice].
    Van Diest E; Stoffelen E; Wydooghe L; Van Duppen D; Seuntjens L; Van der Stuyft P
    Ned Tijdschr Geneeskd; 2001 Feb; 145(8):361-6. PubMed ID: 11257816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary prevention of cardiovascular diseases by lipid-lowering treatment in German general practice: results from GPs ignoring guidelines and risk calculators.
    Oriol-Zerbe C; Abholz HH
    Eur J Gen Pract; 2007; 13(1):27-34. PubMed ID: 17366291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyslipidemias and the primary prevention of cardiovascular disease: analysis of the FAMUS primary care register.
    Xhignesse M; Laplante P; Niyonsenga T; Courteau J; Grant AM
    Can J Cardiol; 2000 Jul; 16(7):879-85. PubMed ID: 10934306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.
    Cuspidi C; Meani S; Salerno M; Severgnini B; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
    Blood Press; 2004; 13(3):144-51. PubMed ID: 15223722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The PreFord Study. A prospective cohort study to evaluate the risk of a cardiovascular event (overall-collective) as well as a prospective, randomized, controlled, multicentre clinical intervention study (high-risk-collective) on primary prevention of cardiovascular diseases in the Ford Motor Company employees in Germany].
    Gysan DB; Latsch J; Bjarnason-Wehrens B; Albus C; Falkowski G; Herold G; Mey E; Heinzler R; Montiel G; Schneider CA; Stützer H; Türk S; Weisbrod M; Predel HG
    Z Kardiol; 2004 Feb; 93(2):131-6. PubMed ID: 14963679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospective comparison of the flow chart for laboratory investigations for anaemia from the Dutch College of General Practitioners' guideline 'Anaemia' with a self-developed, substantive and logistical alternative flow chart].
    Oosterhuis WP; van der Horst M; van Dongen K; Ulenkate HJ; Volmer M; Wulkan RW
    Ned Tijdschr Geneeskd; 2007 Oct; 151(42):2326-32. PubMed ID: 18064935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost of cardiovascular risk factor prevention in middle-aged French men. The PRIME study].
    Marques-Vidal P; Arveiler D; Amouyel P; Ducimetière P; Ferrières J
    Rev Epidemiol Sante Publique; 2001 Dec; 49(6):541-9. PubMed ID: 11845103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular medications in primary care: treatment gaps and targeting by absolute risk.
    Rafter N; Connor J; Hall J; Jackson R; Martin I; Parag V; Vander Hoorn S; Rodgers A
    N Z Med J; 2005 Oct; 118(1223):U1676. PubMed ID: 16224500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports].
    Silber S; Richartz BM; Brilmayer M;
    Herz; 2006 Dec; 31(9):836-46, 848. PubMed ID: 17180646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hospital-based network for hyperlipidaemia management and cardiovascular disease prevention.
    Pujia A;
    Nutr Metab Cardiovasc Dis; 2002 Aug; 12(4):198-203. PubMed ID: 12514940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of patients with acute coronary syndromes in the Netherlands in 2000-2001; a comparison with other European countries and with the guidelines].
    Nieuwlaat R; Vermeer F; Scholte op Reimer WJ; Boersma E; van 't Hof AW; Simoons ML
    Ned Tijdschr Geneeskd; 2004 Sep; 148(38):1878-82. PubMed ID: 15497784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001.
    Hartz I; Njølstad I; Eggen AE
    Eur Heart J; 2005 Dec; 26(24):2673-80. PubMed ID: 16204260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to a guideline on cardiovascular prevention: a comparison between general practitioners and practice nurses.
    Voogdt-Pruis HR; Van Ree JW; Gorgels AP; Beusmans GH
    Int J Nurs Stud; 2011 Jul; 48(7):798-807. PubMed ID: 21176903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
    Kok L; Engelfriet P; Jacobs-van der Bruggen MA; Hoogenveen RT; Boshuizen HC; Verschuren MW
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):371-6. PubMed ID: 19305351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between te general practice guidelines for the diagnosis of hypertension and the indication for treatment and practice in the Nijmegen region, the Netherlands, 1983-2001].
    Bakx JC; Deunk L; van Gerwen WH; van Aalst M; van den Hoogen HJ; van den Bosch WJ
    Ned Tijdschr Geneeskd; 2003 Mar; 147(13):612-5. PubMed ID: 12701396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of guidelines on health care use for the management of dyslipidemia in two Canadian provinces, Alberta and Nova Scotia, from 1990 to 2001.
    Joffres MR; Kamath TV; Williams GR; Casey J; Svenson LW
    Can J Cardiol; 2004 Jun; 20(8):767-72. PubMed ID: 15229757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary risk estimates and decisions on lipid-lowering treatment in primary prevention: comparison between general practitioners, internists, and cardiologists.
    Vancheri F; Strender LE; Montgomery H; Skånér Y; Backlund LG
    Eur J Intern Med; 2009 Oct; 20(6):601-6. PubMed ID: 19782921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of indicators for assessing the quality of prescribing of lipid-lowering drugs: data from the pharmacotherapeutic quality circles in Hesse, Germany.
    Schubert ; Köster ; Ihle P; von Ferber L
    Int J Clin Pharmacol Ther; 2001 Nov; 39(11):492-8. PubMed ID: 11727970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
    Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
    Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inadequate management of dyslipidaemic patients in France. Results of the Odyssée study].
    Ferrières J; Elbaz M; Maupas E; Carriè D; Puel J
    Arch Mal Coeur Vaiss; 2004 Mar; 97(3):187-93. PubMed ID: 15106741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.